Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 3
1980 1
1985 2
1986 4
1987 2
1988 1
1989 1
1991 1
1992 1
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2001 1
2002 1
2004 2
2005 5
2007 1
2008 2
2009 2
2010 2
2011 5
2012 4
2013 4
2014 2
2015 3
2017 1
2018 4
2019 2
2020 8
2021 11
2022 2
2023 6
2024 8
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance.
Bujanda L, Nyssen OP, Ramos J, Bordin DS, Tepes B, Perez-Aisa A, Pavoni M, Castro-Fernandez M, Lerang F, Leja M, Rodrigo L, Rokkas T, Kupcinskas J, Jonaitis L, Shvets O, Gasbarrini A, Simsek H, Phull PS, Buzás GM, Machado JC, Boltin D, Boyanova L, Tonkić A, Marlicz W, Venerito M, Vologzanina L, Fadieienko GD, Fiorini G, Resina E, Muñoz R, Cano-Català A, Puig I, García-Morales N, Hernández L, Moreira L, Megraud F, Morain CO, Montes M, Gisbert JP; Hp-EuReg investigators; Hp-EuReg investigators. Bujanda L, et al. Am J Gastroenterol. 2024 Apr 1;119(4):646-654. doi: 10.14309/ajg.0000000000002600. Epub 2023 Nov 17. Am J Gastroenterol. 2024. PMID: 37983769
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
Olmedo L, Calvet X, Gené E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Perez-Aisa Á, Lucendo AJ, Rodrigo L, Sarsenbaeva AS, Khlinov IB, Fadieienko G, Zaytsev O, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Jonaitis L, Núñez Ó, Pellicano R, Hernández L, Gridnyev O, Kupcinskas J, Gasbarrini A, Boltin D, Niv Y, Babayeva G, Marcos-Pinto R, Tepes B, Venerito M, Papp V, Lerang F, Leja M, Phull PS, Marlicz W, Doulberis M, Smith SM, Milivojevic V, Kunovsky L, Mestrovic A, Matysiak-Budnik T, Simsek H, Cano-Català A, Puig I, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg investigators*. Olmedo L, et al. Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804. Gut. 2024. PMID: 39461739 Free PMC article.
PKCα Activation via the Thyroid Hormone Membrane Receptor Is Key to Thyroid Cancer Growth.
Campos Haedo MN, Díaz Albuja JA, Camarero S, Cayrol F, Sterle HA, Debernardi MM, Perona M, Saban M, Ernst G, Mendez J, Paulazo MA, Juvenal GJ, Díaz Flaqué MC, Cremaschi GA, Rosemblit C. Campos Haedo MN, et al. Among authors: perona m. Int J Mol Sci. 2024 Nov 13;25(22):12158. doi: 10.3390/ijms252212158. Int J Mol Sci. 2024. PMID: 39596225 Free PMC article.
2-iodohexadecanal induces autophagy during goiter involution.
Salvarredi L, Oglio RA, Rodriguez C, Navarro D, Perona M, Dagrosa MA, Juvenal GJ, Thomasz L. Salvarredi L, et al. Among authors: perona m. Prostaglandins Other Lipid Mediat. 2024 Jun;172:106819. doi: 10.1016/j.prostaglandins.2024.106819. Epub 2024 Feb 10. Prostaglandins Other Lipid Mediat. 2024. PMID: 38346574
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg).
Martínez-Domínguez SJ, Nyssen OP, Lanas Á, Alfaro E, Jonaitis L, Mahmudov U, Voynovan I, Gülüstan B, Rodrigo L, Fiorini G, Perez-Aisa Á, Tejedor-Tejada J, Tepes B, Vologzanina L, Mammadov E, Lerang F, Oğlu QFV, Bakulina NV, Abdulkhakov R, Tatiana I, Butler TJ, Sarsenbaeva AS, Bumane R, Lucendo AJ, Romano M, Bujanda L, Abdulkhakov SR, Zaytsev O, Pabón-Carrasco M, Keco-Huerga A, Denkovski M, Huguet JM, Perona M, Núñez Ó, Pavoni M, Fadieienko G, Alekseenko S, Smith SM, Hernández L, Kupcinskas J, Bordin DS, Leja M, Gasbarrini A, Gridnyev O, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Gisbert JP; Hp‐EuReg Investigators. Martínez-Domínguez SJ, et al. Among authors: perona m. Helicobacter. 2024 Jul-Aug;29(4):e13111. doi: 10.1111/hel.13111. Helicobacter. 2024. PMID: 39001621
Oxygenation improvement and duration of prone positioning are associated with ICU mortality in mechanically ventilated COVID-19 patients.
De Rosa S, Sella N, Bellani G, Foti G, Cortegiani A, Lorenzoni G, Gregori D, Boscolo A, Cattin L, Elhadi M, Fullin G, Garofalo E, Gottin L, Grassetto A, Maggiore SM, Momesso E, Peta M, Poole D, Rona R, Tiberio I, Zanoletti A, Rezoagli E, Navalesi P; SIAARTI Study Group. De Rosa S, et al. Ann Intensive Care. 2025 Jan 28;15(1):20. doi: 10.1186/s13613-025-01438-y. Ann Intensive Care. 2025. PMID: 39875763 Free PMC article.
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg).
Casas Deza D, Alcedo J, Lafuente M, López FJ, Perez-Aisa Á, Pavoni M, Tepes B, Jonaitis L, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Bujanda L, Lucendo AJ, Brglez Jurecic N, Denkovski M, Vologzanina L, Rodrigo L, Martínez-Domínguez SJ, Fadieienko G, Huguet JM, Abdulkhakov R, Abdulkhakov SR, Alcaide N, Velayos B, Hernández L, Bordin DS, Gasbarrini A, Kupcinskas J, Babayeva G, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Lerang F, Boltin D, Mestrovic A, Smith SM, Venerito M, Boyanova L, Milivojevic V, Doulberis M, Kunovsky L, Parra P, Cano-Català A, Moreira L, Nyssen OP, Megraud F, Morain CO, Gisbert JP; Hp-EuReg investigators. Casas Deza D, et al. Am J Gastroenterol. 2025 Feb 4. doi: 10.14309/ajg.0000000000003351. Online ahead of print. Am J Gastroenterol. 2025. PMID: 39902822
Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy.
Garcia Fallit M, Peña Agudelo JA, Nicola Candia AJ, Gonzalez N, Pérez Küper M, Zampini Y, Romero AC, Sobarzo C, Sánchez Rojas I, Durán H, Perona M, Ripari LB, Videla-Richardson GA, Zanetti FA, Lozano T, Casares N, Lasarte JJ, Candolfi M. Garcia Fallit M, et al. Among authors: perona m. Life Sci. 2025 Oct 1;378:123822. doi: 10.1016/j.lfs.2025.123822. Epub 2025 Jun 27. Life Sci. 2025. PMID: 40582634
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple Therapy.
Nyssen OP, Montes N, Pérez-Aísa Á, Martínez-Domínguez SJ, Tejedor-Tejada J, Lucendo AJ, Huguet JM, Garre A, Bujanda L, Pabón-Carrasco M, Castro-Fernández M, Perona M, Ortiz-Polo I, Núñez Ó, Marcos MS, Gómez Rodríguez BJ, Loro AM, Bermejo F, Barrio J, Iyo E, Alonso EB, Flores V, Keco-Huerga A, Mata-Romero P, Gomez-Camarero J, Fernández-Bermejo M, Cajal MD, Martin-Holgado D, Velayos B, Planella M, Alcaide N, Blanco ABP, Fernández-Salazar L, Pajares Villarroya R, Alonso MS, Mejide PP, Jiménez-Moreno M, Perelló A, Pascual-Mato M, Albéniz E, Hernández G, Gonzalez MF, Sanchez SM, de Castro JDF, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Gisbert JP; Hp‐EuReg investigators. Nyssen OP, et al. Among authors: perona m. Aliment Pharmacol Ther. 2025 Jul 4. doi: 10.1111/apt.70261. Online ahead of print. Aliment Pharmacol Ther. 2025. PMID: 40616238
97 results